Core Insights - The stock market has experienced significant movements among top gainers, with notable price changes and trading volumes in various sectors [1] Company Summaries - Beasley Broadcast Group, Inc. (BBGI) saw its stock price surge to $17.74, a 338.27% increase, with a trading volume exceeding 35 million shares, following a third-quarter revenue report of $51 million [2][7] - ASPAC III Acquisition Corp. (ASPC) experienced a stock price increase to $24.3, up by 131.87%, on a volume of approximately 2.87 million shares, driven by investor interest in potential mergers or acquisitions [3][7] - ASPAC's unit, ASPCU, also saw its stock rise to $24.11, a 129.40% increase, with a trading volume of around 51,758 shares, reflecting similar investor sentiment [3][7] - Enveric Biosciences, Inc. (ENVB) had its stock price increase to $10.15, up by 71.61%, with trading volume over 32 million shares, following a significant patent allowance for its EVM301 Series molecules [4][7] - Creative Global Technology Holdings Limited (CGTL) reported a stock price climb to $1.09, a 65.18% increase, with over 21 million shares traded, highlighting investor interest in its recycled consumer electronics business model [5][7] Market Dynamics - The movements in stock prices underscore the dynamic nature of the market, with companies across various sectors experiencing significant volatility, attracting investor attention for future developments [6]

Market Overview - U.S. stocks showed mixed performance with the Dow Jones index gaining over 200 points, up 0.50% to 47,799.21, while NASDAQ fell 0.18% to 23,533.49 and S&P 500 rose 0.11% to 6,849.05 [1] - Industrial shares increased by 0.8%, while information technology stocks decreased by 0.6% [1] Commodity Market - U.S. crude oil inventories decreased by 1.812 million barrels, contrasting with a gain of 0.574 million barrels in the previous week and against market expectations of a 2.3 million barrel decline [2][9] - Oil prices fell by 0.8% to $57.78, while gold decreased by 0.3% to $4,225.70; silver rose by 0.5% to $61.150, and copper increased by 0.7% to $5.3550 [4] European Market - European shares were mixed, with the eurozone's STOXX 600 rising 0.05%, Spain's IBEX 35 Index up 0.12%, and London's FTSE 100 up 0.23%. In contrast, Germany's DAX 40 fell 0.17% and France's CAC 40 decreased by 0.45% [5] Asian Market - Asian markets closed mostly lower, with Japan's Nikkei down 0.10%, Hong Kong's Hang Seng up 0.42%, China's Shanghai Composite down 0.23%, and India's BSE Sensex down 0.32% [6] Company Performance - Photronics Inc (NASDAQ:PLAB) shares surged 35% to $34.66 after reporting better-than-expected fourth-quarter results and issuing first-quarter guidance above analyst estimates [8] - Braze Inc (NASDAQ:BRZE) shares increased by 16% to $35.42 following an upward revision of FY2026 adjusted EPS and sales guidance after strong third-quarter revenue [8] - Enveric Biosciences, Inc. (NASDAQ:ENVB) shares rose 78% to $10.56 after receiving a Notice of Allowance for a patent application related to its EVM301 Series molecules [8] - AeroVironment, Inc. (NASDAQ:AVAV) shares fell 10% to $252.56 after reporting mixed earnings and guidance [8] - Mama's Creations Inc (NASDAQ:MAMA) shares dropped 9% to $13.03 despite reporting positive third-quarter financial results [8] - Pomdoctor Limited (NASDAQ:POM) shares plummeted 73% to $1.4799 [8] Economic Indicators - U.S. compensation costs for civilian workers rose by 0.8% in the third quarter, compared to a 0.9% gain in the previous period [7]

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining more than 200 points on Wednesday.The Dow traded up 0.50% to 47,799.21 while the NASDAQ fell 0.18% to 23,533.49. The S&P 500 also rose, gaining, 0.11% to 6,849.05.Check This Out: Jim Cramer Says Avoid This Stock: ‘The Only Thing Worse Than Housing Is…’Leading and Lagging SectorsIndustrials shares jumped by 0.8% on Wednesday.In trading on Wednesday, information technology stocks fell by 0.6%.Top HeadlineU.S. crude oil inventori ...

Company Performance - Chewy Inc. reported adjusted earnings of 32 cents per share for the third quarter, surpassing the consensus estimate of 13 cents and falling within management's guidance of 28-33 cents [2] - The company achieved sales of $3.117 billion, reflecting an 8.3% year-over-year increase, compared to the consensus of $3.099 billion and management's guidance of $3.07 billion to $3.1 billion [2] Market Trends - U.S. stocks showed mixed performance, with the Dow Jones index increasing by approximately 100 points, up 0.23% to 47,669.92, while the NASDAQ decreased by 0.19% to 23,530.68 [1] - The S&P 500 rose slightly by 0.02% to 6,842.14 [1] - In sector performance, industrial shares increased by 0.8%, while information technology stocks fell by 0.6% [1] Commodity Prices - Oil prices decreased by 0.6% to $57.92, while gold prices fell by 0.2% to $4,227.60 [4] - Silver prices rose by 0.3% to $60.990, and copper prices increased by 0.8% to $5.3615 [4] Stock Movements - A SPAC III Acquisition Corp. shares surged by 336% to $45.69, while Beasley Broadcast Group, Inc. shares rose by 135% to $9.52 [8] - Enveric Biosciences, Inc. shares increased by 102% to $11.94 following a Notice of Allowance for a patent application related to its EVM301 Series molecules [8] - Conversely, WORK Medical Technology Group LTD shares plummeted by 86% to $0.7876, and Agape ATP Corporation shares fell by 82% to $0.2332 [8]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential investment opportunities before the market opens [1] Group 1: Premarket Gainers - A SPAC III Acquisition Corp. (ASPC) has increased by 227% to $34.30 [3] - Enveric Biosciences, Inc. (ENVB) has risen by 113% to $12.65 [3] - ESH Acquisition Corp. (ESHA) is up 32% at $15.57 [3] - SU Group Holdings Limited (SUGP) has also increased by 32% to $8.20 [3] - Horizon Space Acquisition I Corp. (HSPO) is up 31% at $23.03 [3] - Mawson Infrastructure Group Inc. (MIGI) has risen by 18% to $5.45 [3] - Velo3D, Inc. (VELO) is up 17% at $7.72 [3] - Braze, Inc. (BRZE) has increased by 16% to $35.73 [3] - Cadrenal Therapeutics, Inc. (CVKD) is up 10% at $11.00 [3] - Palisade Bio, Inc. (PALI) has risen by 10% to $2.10 [3] Group 2: Premarket Losers - Aimei Health Technology Co., Ltd (AFJK) has decreased by 46% to $47.00 [4] - JX Luxventure Group Inc. (JXG) is down 33% at $5.73 [4] - Oriental Culture Holding LTD (OCG) has fallen by 29% to $7.21 [4] - Lakeland Industries, Inc. (LAKE) is down 26% at $11.06 [4] - WORK Medical Technology Group LTD (WOK) has decreased by 19% to $4.50 [4] - ReTo Eco-Solutions, Inc. (RETO) is down 16% at $2.73 [4] - Exicure, Inc. (XCUR) has fallen by 11% to $6.43 [4] - Denali Therapeutics Inc. (DNLI) is down 7% at $18.21 [4] - SMJ International Holdings Inc. (SMJF) has decreased by 7% to $4.50 [4] - Cracker Barrel Old Country Store, Inc. (CBRL) is down 6% at $25.30 [4]

Core Insights - Braze Inc (NYSE:BRZE) shares increased significantly in pre-market trading after the company raised its FY2026 adjusted EPS and sales guidance due to better-than-expected third-quarter revenue [1] - The company reported quarterly adjusted earnings of $0.06 per share, meeting analyst estimates, while quarterly revenue reached $190.84 million, surpassing the Street estimate of $184.08 million [1] - Following these announcements, Braze shares jumped 14.2% to $35.00 in pre-market trading [1] Company Performance - Braze's quarterly adjusted earnings were $0.06 per share, aligning with analyst expectations [1] - The reported quarterly revenue of $190.84 million exceeded the anticipated $184.08 million [1] - The positive financial results led to a 14.2% increase in share price during pre-market trading [1]

Core Viewpoint - Compass Pathways' disappointing Phase III trial results for psilocybin treatment of treatment-resistant depression (TRD) led to a significant decline in stock prices across the psychedelic drug sector, with Compass's stock dropping by 49% [1][2]. Group 1: Trial Results and Market Reaction - The Phase III trial (COMP005) for COMP360 showed a MADRS score improvement of only 3.6 points compared to placebo, which, while statistically significant, fell short of analysts' expectations of at least 5 points and was lower than the company's previous Phase II data of 6.6 points [2][3]. - The underwhelming results raised concerns about the efficacy, sustainability, and commercial potential of psilocybin, leading to a broader sell-off in the psychedelic drug sector [2][3]. - Other companies in the psychedelic space, such as atai Life Sciences, MindMed, Cybin, and GH Research, experienced stock declines ranging from 5% to over 15% following the news [2][3]. Group 2: Impact on Other Companies - atai Life Sciences, with its DMT oral film in Phase II trials for TRD, saw its stock drop by over 15% [3]. - MindMed, which is in Phase III trials for an LSD derivative targeting major depressive disorder, experienced a stock decline of approximately 6% [3]. - Cybin's stock, which is developing an oral psilocin treatment for depression in Phase II trials, fell by about 5% [3]. - GH Research, with its inhaled mebufotenin candidate in Phase II for TRD, also saw a stock decrease of around 5% [3]. - Other psychedelic stocks, including Clearmind Medicine, Enveric Biosciences, and Bright Minds Biosciences, faced significant declines on the same day [4].

Company Performance - TJX Companies Inc reported better-than-expected fourth-quarter FY25 earnings, with sales remaining flat year-on-year at $16.4 billion, surpassing analyst consensus of $16.20 billion [2] - Overall comparable store sales increased by 5%, driven by a rise in customer transactions, and adjusted EPS was $1.23, beating the consensus estimate of $1.16 [2] Stock Movements - Enveric Biosciences, Inc. shares surged 116% to $2.54 following the announcement of promising results for its non-hallucinogenic psychedelic compounds [8] - Mullen Automotive, Inc. shares rose 59% to $3.72 after its vehicles were added to a government purchasing contract [8] - Porch Group, Inc. shares increased by 80% to $6.80 after reporting fourth-quarter financial results [8] - Flywire Corporation shares dropped 40% to $10.67 due to worse-than-expected fourth-quarter results [8] - AppLovin Corporation shares fell 17% to $311.57 amid new short reports targeting the stock [8] - Geron Corporation shares decreased by 31% to $1.6250 following its quarterly results [8] Economic Indicators - U.S. mortgage applications declined by 1.2% for the week ending Feb. 21 [9] - U.S. crude oil inventories fell by 2.332 million barrels, contrary to market expectations of a 2.54 million barrel increase [9] - Sales of new single-family homes in the U.S. decreased by 10.5% to an annualized rate of 657,000 in January [9] - Building permits also declined by 0.6% to an annualized rate of 1.473 million in January [9]

Market Overview - U.S. stocks showed mixed performance with the Nasdaq Composite gaining approximately 150 points, while the Dow decreased by 0.06% to 43,594.06 and the S&P 500 rose by 0.46% to 5,983.30 [1] - Information technology shares increased by 1.4%, while consumer staples shares fell by 1.6% [1] Company Earnings - Lowe's Companies, Inc. reported fourth-quarter adjusted earnings per share of $1.93, exceeding the expected $1.84, with quarterly sales of $18.553 billion, a slight decline of 0.3% year-over-year but above the analyst consensus of $18.292 billion [2] - For 2025, Lowe's projects EPS between $12.15 and $12.40, which is below the consensus estimate of $12.51, and total sales are expected to be between $83.5 billion and $84.5 billion, compared to the consensus of $84.56 billion [3] Stock Movements - Enveric Biosciences, Inc. saw its shares surge by 108% to $2.4540 following positive news regarding its non-hallucinogenic psychedelic compounds [8] - Mullen Automotive, Inc. shares increased by 72% to $4.0685 after its vehicles were added to a government purchasing contract [8] - Porch Group, Inc. shares rose by 65% to $6.25 after reporting fourth-quarter financial results [8] - Flywire Corporation's shares dropped by 41% to $10.48 due to worse-than-expected fourth-quarter results [8] - Venus Concept Inc. shares fell by 34% to $0.3540 following several senior management changes [8] - Geron Corporation's shares decreased by 31% to $1.64 after posting quarterly results [8]